Biomonitoring has become the ''gold standard'' in assessing chemical exposures, and has an important role in risk assessment. The pooling of biological specimens-combining multiple individual specimens into a single sample-can be used in biomonitoring studies to monitor levels of exposure and identify exposure trends or to identify susceptible populations in a cost-effective manner. Pooled samples provide an estimate of central tendency and may also reveal information about variation within the population. The development of a pooling strategy requires careful consideration of the type and number of samples collected, the number of pools required and the number of specimens to combine per pool in order to maximise the type and robustness of the data. Creative pooling strategies can be used to explore exposure-outcome associations, and extrapolation from other larger studies can be useful in identifying elevated exposures in specific individuals. The use of pooled specimens is advantageous as it saves significantly on analytical costs, may reduce the time and resources required for recruitment and, in certain circumstances, allows quantification of samples approaching the limit of detection. In addition, the use of pooled samples can provide population estimates while avoiding ethical difficulties that may be associated with reporting individual results.
INTRODUCTION
Exposure assessment is an essential component of chemical risk assessment, and regulatory and legislative bodies require exposure data to assess risks and to design and implement intervention strategies. Traditionally, indirect methods such as ambient environmental monitoring or self-administered questionnaires were used for the assessment and estimation of chemical exposures. 1 However, with the rapid advancement of sensitive analytical techniques, biomonitoring has become the ''gold standard'' for the characterisation of chemical exposure. 2, 3 Biomonitoring provides a direct measure of aggregate exposures at the time of sampling, rather than being limited to exposure estimates based on multiple measurements in multiple compartments (such as food, dust, and air) that may have contributed to that exposure. For the purposes of this paper, ''biomonitoring'' refers specifically to chemical biomonitoring and is defined as the systematic collection of human tissues and fluids such as blood, urine, hair or milk for the analysis of chemical contaminants and their metabolites and transformation products to facilitate exposure assessment. 4 Further, ''pooling'' refers to combining multiple individual specimens into a single sample using a set of grouping criteria, for example, age, sex and so on. The focus of this review is the use of pooled samples for chemical biomonitoring; however, many of the principles described below can also be applied to the analysis of biomarkers of exposure and biomarkers of effect, such as clinical chemistry measures and DNA adducts.
Over the past decade, the National Research Centre for Environmental Toxicology (Entox) at the University of Queensland in Australia has coordinated numerous biomonitoring studies of the general Australian population for selected persistent organic pollutants (POPs). Human biological specimens, including blood, urine and breast milk, have been collected and archived by Entox for the National Environmental Specimen Bank. The majority of these biomonitoring studies have used pooled samples obtained by combining de-identified, surplus pathology specimens. Pathology samples are readily available in Australia and likely also in other countries and represent a potentially valuable resource for chemical biomonitoring.
In traditional epidemiological settings, emphasis has been placed on the importance of collecting and analysing individual specimens for biomonitoring. This sampling strategy represents a hyperconservative approach that preserves the ability to relate individual outcomes to individual exposures, but this may not always be the optimal choice for all biomonitoring studies. For example, individual specimens are collected, analysed and archived for the German Environmental Survey and the German Environmental Specimen Bank; 5 however, much of the overall interpretation of the data is based on quasi-pooled or -stratified results, such as investigations of trends in mean body burden for a particular chemical. For example, the reported decrease in urinary phthalate metabolite concentrations in young adults in Germany occurring contemporaneously with decreasing industrial production/consumption of the precursor compound. 5 The same temporal trend could have been observed and the same conclusion reached at a considerably reduced cost if a pooled sampling strategy had been used.
The use of pooled samples for biomonitoring is gradually becoming more popular. The World Health Organisation has coordinated four global studies, including the Global Monitoring Plan initiated in 2007, to monitor a range of POPs in ''core media'', including pooled breast milk. [6] [7] [8] [9] This pooled sampling approach is an efficient method for identifying trends in POPs exposures and has been used as a strategy to satisfy Articles 11 and 16 of the Stockholm Convention by identifying priority POPs in the population and monitoring the levels of these POPs over time. 7 The first regional monitoring report for the Western Europe and Other States group 9 10 This study provides evidence for the successful use of pooled samples to assess human exposures to POPs in several countries worldwide.
This review critically examines the potential uses of, approaches to and limitations of pooled samples for biomonitoring of environmental chemicals in contrast to study designs using individual specimens. We explore the rationale for undertaking biomonitoring studies and assess the effectiveness of pooled samples for meeting different study aims. Further, we discuss a range of potentially new approaches to developing pooling strategies, and creative applications of these pooled samples, with the aim of identifying opportunities to expand the usefulness of pooled samples in the areas of human biomonitoring and epidemiological research.
STATISTICAL CONSIDERATIONS
The design of pooled sampling efforts for the characterisation of biomarker concentrations in a population should be guided by the purpose and goals of the study. [11] [12] [13] According to the biological averaging assumption, 14 the measured concentration in a pooled specimen is comparable to the arithmetic mean of concentration of individual specimens making up the pool. Thus pool-based analyses provide a tool for estimating the central tendency (i.e. arithmetic mean) of a population or subpopulation, which in turn is useful for the assessment of relative exposure levels among subpopulations or for monitoring trends in levels over time or space.
For many applications, estimation of the central tendency and variation within a population or subpopulation is of interest. One such example is the identification of upper and lower percentiles of concentrations in the general population for use as reference values to define the ''typical'' range of biomarker concentrations. Such reference values can be used in the evaluation of data from persons who may have experienced unusually high exposures in order to assess whether their exposure exceeds the range of exposures in the general population. 15 Data generated from pooled samples cannot be used to calculate the geometric mean or median of a population and, alone, it cannot describe the population variance (Table 1) .
Under some conditions, however, pooling approaches can be used to estimate variability of exposures in a population. For example, if the biomarker concentration is normally distributed in the population, then measured concentrations in multiple pooled samples drawn from that population will also be normally distributed with the same mean. Under ideal conditions, and with simple assumptions about the normality of the underlying population distribution, the population variance can be estimated based on the variance in the measured concentrations in multiple independently constituted pools. 11 However, the application of this ideal concept is hampered by three factors: (1) the contribution of measurement error to variation in pooled sample measurements; (2) the contribution of pooling error to variation in pooled sample measurements; and (3) the shape of the underlying population distributions of chemical biomarker concentrations, which are rarely, if ever, normal distributions.
In the context of analysis of trace levels of environmental chemicals in biological matrices, measurement error may be important when estimating population variation based on variation in measurements of multiple pools. For example, for the quantification of mercury levels in whole blood, measurement error may be considered negligible (RSDo3%, n ¼ 815), 16 but for the analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in serum, the coefficient of variation is greater (%RSDo16%, n ¼ 20), 17 and measurement error may be significant. The extra handling and processing needed to physically pool samples can introduce a separate and independent source of error to the analysis, which Schisterman et al. 12, 13 termed as ''pooling error''. Pooling error may be particularly relevant for pooled samples consisting of a large number of individual specimens, wherein the error is additive.
Pooling error arises from the physical errors associated with extracting and transferring precise volumes from multiple individual samples into the physical pool. Errors associated with these procedures can be amplified if the pooling procedure relies upon a weighting scheme. For example, Caudill 18 has proposed a pooling scheme in which the volume of sample from each individual included in the pool is proportional to the population statistical sample weight assigned to that individual. In such a case, random error in the physical process of pooling may be magnified or distorted in that error in extracting or compositing samples from highly weighted individuals will impact the overall pool error to a greater extent. Quantifying and characterising this source of error may require physical experimentation, where the pooling process is replicated on stock solutions in order to evaluate the relative magnitude of this source of error compared with other potential sources, such as measurement error.
Caudill 11, 18 has outlined statistical approaches to estimate population variance and specific percentiles based on the analysis of pooled samples for US's National Health and Nutrition Examination Survey (NHANES) data. The approach relies on (1) assumption of lognormality in the underlying data; (2) the analysis of multiple pools to allow estimation of population variance; and (3) repeated analytical determinations of each pool to allow for estimation of variance from measurement error. Based on observed variation in the pool measurements and the estimation of measurement error, the variance of the underlying population can be estimated. 18 The confidence in the estimate of underlying population variance increases with increasing numbers of pools from a given population strata. Similarly, the accuracy of the estimate of measurement error increases with increasing numbers of repeated analytical determinations per pool. These estimates of across-pool and within-pool variance can be combined with the weighted arithmetic mean of the measured pool concentrations to estimate both the geometric mean and specified percentiles in the population, again under the assumption of log-normality for the population distribution. However, to the extent that the underlying population distribution departs from log normality, these approaches will not provide accurate estimations of population variance or distribution.
POOLING VERSUS RANDOM SAMPLING STRATEGIES Recruitment One of the difficulties in assessing environmental exposures, particularly in population-wide studies, is the labour and resourceintensive nature of sampling and analysis of a large number of samples, especially for infants and young children. Inherent in such studies is the bias introduced through sampling design and participant selection (Table 1) . When the aim of the study is to survey the ''general population'', selection bias must be a real concern. There is consistent evidence that women and persons with higher socioeconomic status are more likely to participate in scientific studies, 19 especially when the study burden is onerous. Numerous studies focus on associations between environmental exposure and socioeconomic status or ethnicity [20] [21] [22] [23] and selection bias can result in invalid conclusions if this bias has not been adequately addressed in the sampling design. A study that involves the collection of de-identified samples with equal representation of ethnic and socioeconomic groups may be more acceptable and help reduce this selection bias.
Individual specimens collected as part of a study and pooled post hoc can be advantageous in that specimens collected during the course of an unrelated study can be exploited to answer research questions beyond the scope of the original study without requiring additional recruitment, which might be prone to bias, as discussed above. For example, biological specimens collected during a cohort study investigating fluoride status can be used to monitor exposure to unrelated environmental chemicals.
A largely untapped resource is specimens collected during the course of routine pathology testing, which can similarly be used to explore trends in certain subsets of the population. For example, in a study conducted at Entox by Toms et al., 24 de-identified, surplus serum samples (n ¼ 2420) collected as part of routine pathology testing were stratified by age and sex, pooled (n ¼ 84) and analysed to investigate the association between concentration of polybrominated diphenyl ethers and age. The authors found that serum concentration peaked at 2.6-3 years (51 ± 36 ng/g lipid), after the typical cessation of breastfeeding, and concluded that young children have an additional exposure source for these chemicals.
However, the use of pathology samples introduces potential bias into the study population, as the individuals providing the sample may not be truly representative of the normal population and may have some disturbance or perturbation of normal physiology. In order to assess this potential bias, a component of the Australian National Dioxins Program 25 investigated the levels of dioxins and dioxin-like chemicals in pathology samples (i.e. potentially ''sick'' individuals) compared with samples collected for insurance assessments (i.e. ''healthy'' individuals) to determine if there were detectable differences between the two groups. For the majority of compounds, the normalised difference between the two groups was o20%, which may be explained by variations in analytical reproducibility, and the authors concluded that it was unlikely that sampling bias would result from the use of pathology samples.
Financial Cost
In most circumstances, the single most motivating factor for using pooled samples in a study design is the significant expense associated with the analytical component of chemical analysis. Analytical methods with suitably sensitive limits of detection, such as high resolution or tandem mass spectrometry, are expensive and thus not readily accessible to a large number of laboratories. Furthermore, the logistics of collecting, storing and analysing samples becomes more complicated as the number of samples increases, such as when individual specimens are used in a random sampling design. The most obvious solution to this problem is to analyse fewer samples. Pooling allows a large number of samples to be systematically sorted and combined in such a way as to investigate particular elements of a population or study design while performing fewer analyses. Where the study aims can be achieved using pooled samples, hundreds of individual specimens can be combined to form a single pool, providing a cost-effective study design through significantly reduced analytical costs. 26 This of course does not negate the time and resources required to collect, store and pool the individual specimens.
Using a pooling strategy involves a trade-off between the cost of analysis and the amount of information that can be gleaned from the data ( Table 1) . As discussed above, analysis of a pooled sample in which each individual specimen making up the pool is present in equal volume provides an estimate of the arithmetic mean of the underlying population (see Statistical considerations). If the underlying population data are highly skewed, an arithmetic mean estimate may be of limited use. Furthermore, estimating population variance requires analysis of multiple pools from the population, 11, 18 and the confidence in both the estimate of the arithmetic mean and in the estimate of population variance is limited unless many pools are generated and analysed. Given that the analytical component of analysis is usually the most expensive, pooling can be a useful strategy where budget constraints exist, as long as the limitations in the resulting measurements are understood and conveyed.
Analytical Results Subject: to a Limit of Detection As with any biomonitoring study, there is the question of how to approach analytical results that are less than the limit of detection (LOD). A significant benefit of using a pooled sample design is that when the specimen volume is limited, pooling many specimens may allow achievement of a lower method LOD than available with individual specimens (Table 1) , where an increased total sample volume can facilitate a larger concentration factor during extraction. As a result, a more accurate estimation of mean concentration for a population group may be available via the pooling approach than from analysis of individual specimens. 11 For example, the Canadian Health Measures Study utilises a stratified, weighted random sampling procedure to collect biological samples representative of the Canadian population. 27 In the initial stages of the study, 2.7-ml serum samples were used to measure the concentration of a range of POPs in the general population. However, the levels of POPs in these samples were frequently below the LOD, limiting the usefulness of the data for establishing national averages. 27 In a follow-up study, Rawn et al. 28 used a pooling strategy to estimate baseline concentrations of polychlorinated dibenzodioxins/furans and polychlorinated biphenyls for the same population. Leftover serum samples with a typical sample volume of 350 ml were pooled, where 80 individuals contributed to a single pool to ensure sufficient sample volume (B25 ml) was available for analysis and to reduce the number of undetected compounds. The pooling strategy allowed for an estimation of national averages for these chemicals where the analysis of individual specimens had proved inadequate. Another scenario where pooled samples are useful is when specimens are precious and/or highly coveted, such as with competing research interests. This is particularly the case for specimens from infants and young children, where sample collection is difficult, for example, urine from non-toilet-trained children, or where volume is strictly limited, for example, venous blood from neonates. For example, in the fourth German Environmental Survey pilot study of pesticide exposures in children, not all the specimens collected could be analysed, with 550 children recruited and only 360-400 specimens available for analysis, because the volume of urine available was too small, and the collection procedures were inadequate, particularly for children aged 0-2 years. 29 In this situation, a pooling strategy would have facilitated the creation of larger sample volumes allowing for further sample enrichment and consequently a concentration above the LOD.
Schisterman and Vexter 12 propose a unique ''pooled-unpooled resampling design'' to quantitate samples that may be oLOD, when cost and sample volume are not prohibitive. In this approach, individual specimens are first analysed individually, then composited into pools and reanalysed as pooled samples. For the specimen that was oLOD when analysed individually, a concentration can be back-calculated using the pooled sample results and the individual results from the other specimens making up the pool. However, this is a resource-intensive approach. As a general guide, Schisterman and Vexter suggest that where the mean is oLOD 12, 13 or when 50% of the data are oLOD, 30,31 random sampling is more efficient than pooling for an accurate estimation of mean and variance.
FORMULATING A POOLING STRATEGY
Pooling specimens for biomonitoring can be particularly efficient and advantageous in targeted studies that have a clear goal or hypothesis that is being tested. A key consideration in formulating a pooling strategy is the question of how many individual specimens to include in each pooled sample. When using deidentified specimens, there is a need to balance having a sufficient number of specimens in a pool to preserve individual anonymity with having an optimal number of pools in each stratum to adequately describe the variance. Collecting replicate samples (two or more pooled samples with the same pooling criteria, so that each strata has a minimum of two data points) and performing duplicate analyses can provide some estimate of measurement and pooling errors in addition to standard analytical quality-control procedures. The more replicate samples available per strata, the more information on variance within that stratum that can be gained.
Bignert 32 used generic computer-generated data to simulate random sampling from normally and log-normally distributed populations to investigate the relationships and trade-offs between the number of individuals per pool, number of pools, variance and cost of analysis using pooled and individual samples. This illustrative study demonstrated that if analytical costs remain constant when the number of individual specimens per pool is increased, a larger number of individuals per pool provides a more accurate estimate of the true mean with the smallest variance. The variance can be reduced further by analysing more pools, but this increases analytical costs. From Bignert's data, the variance between sampling periods decreased from 20% to 14% when the number of individual samples was increased from 6 to 12. The same variance was achieved using two pooled samples, where each pool contained six individual specimens, and analytical costs were reduced by 80%. If more pooled samples were used (n ¼ 5), the variance was reduced to 10%, but analytical costs increased accordingly. Alternatively, if the pool size was increased to contain 12 individual specimens, the variance was reduced to 12% using two pooled samples or 8% using five pooled samples.
When developing a pooling strategy, the approach to data normalisation should also be considered. Under ideal circumstances, researchers would have access to parameters for data normalisation (e.g. lipid content, creatinine or specific gravity measures) of each individual specimen before pooling. If the pool mean is to be normalised, for example, reporting a chemical concentration as x ng/g lipid, then the specimens should be pooled such that each individual contributes an equal amount of lipid but potentially a different volume to the sample pool. Of course, data on lipid content and other similar parametric data are not always available before pooling. If no data normalisation is to be performed, or cannot be performed due to lack of data, the specimens may be pooled by volume, where each individual specimen contributes the same volume to the pool. Under these conditions, the biological averaging assumption holds true only for volumetric concentrations.
Ultimately, the optimal pooling strategy is a function of the aims of the study, the potential outcomes, analytical requirements (LODs, minimum sample volume, etc.) and budget constraints, and will be unique for each study.
REPORTING RESULTS
As stated by the US National Research Council, 3 the ability to generate biomonitoring data has well out-paced our ability to interpret such data in the context of public health, and the ethical and scientific challenges of reporting results in human biomonitoring studies are well documented. [33] [34] [35] [36] The difficulty arises because only a small percentage of the compounds measured routinely have been studied in enough detail to elucidate relationships between exposure, metabolism and toxicity, for example, some pesticides (e.g. chlorpyrifos), metals (e.g. lead) and volatile compounds (e.g. benzene) (Figure 1 ). For most compounds, there is a lack of toxicological or pharmacokinetic data for modelling and/or a lack of epidemiological evidence regarding potential health effects, particularly for chronic low-dose exposures. 33, 34 This means that there is no clear relationship between the chemical or biomarker concentration and toxicity or other health end point, limiting the benefit to an individual from knowing their biomarker concentration. It is also uncommon that a physician or health-care professional can link that concentration to a particular disease and then recommend treatment. 34 Recent efforts have been made to apply available data on pharmacokinetics in order to translate existing chemical-specific risk assessment-based exposure guidance values to corresponding chemical concentrations (parent or metabolite) in blood or urine. 15, 37 This has expanded the number of analytes that can be evaluated in the context of current risk assessments on a population basis; however, these screening values do not provide diagnostic information or improve the utility of biomarker measurements for individual health risk assessment.
Pooling of samples is advantageous when biomonitoring is not used to predict specific health end points but rather to monitor exposure over time, where the individual can be engaged in behaviours to reduce or eliminate exposures to potentially hazardous chemicals. For example, the health effects of bisphenol A are not completely understood, despite the large number of animal studies and well-characterised exposure in multiple human populations. Even though the average urinary concentrations correspond to exposure levels well below the reference dose set by the European Food Safety Authority, 38 there has been widespread community concern, particularly regarding plastic baby bottles, resulting in the ban or voluntary phase-out of selected bisphenol A-containing products in some countries (e.g. Canada, European Union and some parts of United States, and Australia and New Zealand, respectively). In this instance, the public knowledge gained from large-scale biomonitoring studies motivated community action that prompted manufacturers to alter their products so consumers could choose to reduce their exposure.
The use of population-based biomonitoring data, whether from pooled or individual samples, for risk assessment or public health applications raises fewer ethical objections than when the same data are attributable to an individual. 34 For example, the US Centers for Disease Control and Prevention conducts one of the largest biomonitoring studies worldwide (NHANES), whereby thousands of individual specimens from the general population are analysed for a suite of environmental chemicals. The Center does not report individual results-instead results are reported as geometric means with percentile distributions, while care is taken to emphasise that the presence of the chemical does not necessarily imply harm has occurred. These descriptive statistics can convey useful information about the higher distribution and range of levels in the population. 39 The same reasoning can be applied to pooled specimens, as the result from a pooled specimen cannot be attributed to any one individual making up that pool. However, when reporting results at the population level, care needs to be taken to avoid stigmatising a particular ethnic, geographical or professional community. 34 TARGETED POOLING APPROACHES Purposive Sampling and Pooling Strategy Devers and Frankel 40 discuss the use of ''purposive'' sampling during qualitative research, whereby specific individuals, groups, organisations or behaviours are targeted to provide the greatest insight into the research question. Pooling strategy can be viewed in a similar light, where the pooling criteria can be extended beyond age and sex to include variables such as geographic location, socioeconomic status, industry groups and so on. Crosssectional studies with a large number of individual specimens and observed patterns in analyte concentrations, such as NHANES, 41, 42 can be used to generate hypotheses for future studies, such as the association between body burden and disease.
If specific health parameters are available, there is the opportunity to pool samples by disease, where a set of health end points are used as criterion to group samples, and this can be applied to novel research questions. For instance, Thompson et al. 43 pooled serum samples by age, sex and disease state to investigate potential sex differences in elimination pathways of various perfluorinated compounds. Females typically have lower levels of these compounds than males, and it has been suggested that menstruation acts as an additional elimination pathway. To investigate this, samples from adults with regular blood loss (patients undergoing regular drawing of blood to treat conditions such as haemochromatosis and polycythaemia) were compared with subjects with no regular blood loss (patients not undergoing regular treatment). Study designs such as this can be used to target a specific subpopulation (e.g. disease cases compared with controls) to explore exposure-outcome relationships and associations.
Pooling for ''Top-Down'' Exposomics Studies The science of identifying the particular chemical exposures that lead to a biological response is called ''exposomics''. 44 Exposomics studies have traditionally followed a ''bottom-up'' approach in which chemical exposures are characterised based on monitoring data and compared with effect levels determined in toxicology studies to demonstrate the likely cause-effect chain that leads to biological responses observed in a population. Pooled biomonitoring samples have considerable potential to be utilised in the alternative ''top-down'' exposomics study design, where samples are pooled by disease or health parameter and screened for a suite of chemicals to identify statistical correlations between exposures and health parameters.
Extrapolation from Other Studies As mentioned, one of the drawbacks of using pooled samples for biomonitoring is the lack of information about the variability of exposures within a population. As discussed above, the analysis of multiple pools may allow estimation of population variation, albeit with considerable uncertainty. 18 Other approaches can also be explored, based on empirical examination of comparable data sets, that is, to use the variance from other large-scale population studies where individual results are available, and apply these values to pooled samples in a separate study. For example, the distribution of analyte concentrations for the US population as a whole or for specific subpopulations, can be extrapolated from publicly available NHANES data sets to estimate the likely degree of variation in other populations 45 (see examples below). This is particularly true if the factors that lead to population variation in the US population are likely to be applicable to the second study population for which only pooled data are available. Such factors might include population variation in intrinsic elimination kinetics for persistent compounds or variation in dietary patterns leading to similar distributions of intake of trace dietary contaminants. Example 1. Aylward et al. 45 use age-specific data on dioxin-like congeners in serum for the US population to estimate reference values for the Australian population, based on measurements in pooled serum samples from an earlier study. 46 The ratio 95th percentile to the arithmetic mean in each age group of interest was calculated from the US NHANES data set and applied to the Australian pooled data to estimate a plausible 95th percentile for the Australian population. The estimates can be used to: (1) provide information on the variability of dioxin-like congener concentrations in the Australian population, which could not be obtained using pooled samples; (2) provide an estimate of the range within the population; and (3) identify samples (individual or pooled) that exceed the upper reference value, which may indicate elevated exposure.
Example 2. The use of TCDD as a marker for exposure to Agent Orange in Australian veterans 47 was assessed by comparing the ratio of two reference congeners (2,3,4,7,8-pentachlorodibenzofuran and 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin) in individual veteran specimens to pooled samples from the general Australian population 25 and the NHANES 2003-2004 48 data set. The distribution of ratios in the Australian veterans was similar to the distribution in the NHANES data set, and the mean ratios were similar to both the NHANES and Australian general population data sets. Upper-bound background levels were estimated using the method described above, and the authors concluded that there was no elevation of TCDD in Australian veterans compared to the general Australian population.
Specimen Banking
The benefits of environmental specimen banking are well documented. 5, 49, 50 Where cost, storage space and sample volume are not limiting factors, it can be advantageous to store individual specimens to allow flexibility in study design to answer unforseen research questions. However, these factors are often significant impediments to the creation of large, comprehensive specimen banks. Wise and Koster 51 discussed the feasibility of using composite tissue samples when there is either insufficient sample available or when the goal of the research is to provide information about a specific population, rather than a limited number of individuals. For example, as part of the United States National Status and Trends Marine Monitoring Program, composite tissue samples from 50 to 200 fish from a particular site were pooled and archived. 51 This was sufficient because the goal of the Program was to quantify long-term trends in contaminant concentrations in marine environments, and the interest was in the contaminant status of the area not the contaminant status of the individual fish.
The same reasoning can be applied to pooled samples of human tissues and fluids. Pooled samples can alleviate some of the space and financial pressures placed on specimen banks, because a smaller number of samples can be stored, while still being representative of the larger population. Further, pooling increases the total sample volume, and this can be important when there is a need for multiple aliquots of the same sample for different analyses over an extended period of time, for example, analysis of new and emerging chemicals or for the analysis of older known toxicants as improved analytical methodologies become available.
SUMMARY AND CONCLUSIONS
Biomonitoring studies both with and without a pooling strategy can be used for a variety of purposes, 52 including:
1. To monitor levels of exposure and identify exposure trends. This can include investigating variation in exposure and distribution in the general population; 21 monitoring exposures cross-sectionally and longitudinally; monitoring temporal variability (i.e. identifying time trends in exposure); and establishing age distribution patterns. 2. To assist in policy-making and public health planning.
Biomonitoring data can inform chemical risk assessment and management, and this data can be used to evaluate the effectiveness of an intervention strategy or regulation, to leverage government funding, industry action or legal action; for improved product safety; and to identify opportunities for exposure reduction. 3. To identify susceptible populations, assess potential risk associated with specific sites or populations, and record the extent of a community-specific exposure. For example, to provide a targeted assessment of population exposures in suspected environmental ''hotspots'' or in the investigation of clusters of disease that may be related to environmental exposure. 4. To identify exposure sources, the link between exposure and behaviour (e.g. diet) and the relationship between exposure and disease, with the goal of understanding human toxicity and metabolism. 5. To identify chemical exposures that may exceed known toxicity benchmarks 39, 53 and to use the data generated in combination with human reference values and physiologically based pharmacokinetic information to model the relationship between a biomonitoring concentration and existing health-based criteria, such as reference doses or tolerable daily intakes. 34 6. To improve medical diagnoses and treatment and to assist in interpreting clinical problems in cases where specific clinical data describing overt effects of chemical poisoning are available (e.g., acute pesticide poisoning 54 ). 7. To detect emerging exposures that may be unexpected or not specifically targeted for investigation.
3, 4, 33, 34, 55 These biomonitoring goals (goals 1-7) are traditionally achieved using individual specimens; however, pooled samples can be used with some additional benefits. The relatively low resource requirements and cost-effectiveness of studies using pooled samples makes them ideal for screening experiments, hypothesis-generating and pilot studies (goal 7).
Pooled sampling strategies lend themselves in particular to investigations of broad exposure trends within a population, such as temporal or age trends of POPs in the general population (goal 1). In these cases, the pool mean is sufficient to monitor exposures over time, particularly if multiple pools are available per strata, which then gives some indication of the variability of exposures within the population. Or if each pool contains a large number of individual samples, a more reliable estimate of the true mean of the broader population can be made. The type of pooling strategy used will determine the type of information available to meet different goals. For instance, if samples are pooled by demographics, for example, age, geographic location or ethnicity, and results from a particular strata are elevated relative to the others, this may indicate a ''susceptible population'' (goal 3). These results can be used in the same way as results from individual specimens to inform public policy (goal 2).
The application of pooled samples for identifying exposure sources (goal 4) is limited to the nature of the pooling strategy. At most, pooled samples may provide some insight into relative levels of exposure in different locations or communities, but the source of exposure within that specific population would need to be determined using other methods. Goals 5 and 6 cannot be met due to the nature of pooled samples, that is, no individual data available.
Biomonitoring is an extremely valuable tool; however, it is resource-intensive, particularly with respect to analytical capability and cost. Pooling allows a large number of individuals from the population to be sampled at reduced analytical costs and can be useful in overcoming space and financial restrictions associated with specimen-banking. Pooling approaches are most obviously supportive of efforts designed to examine broad trends in chemical exposure over time in the population or to evaluate patterns of exposure level with demographic variables, such as age and sex. However, a range of innovative approaches, including pooling by factors in addition to age and sex (geographic location, socioeconomic status, disease state, etc.), can expand the possible applications of pooled samples. Pooled samples have been an under-utilised resource due to the perception that only limited statistical information is generated; however, the careful selection of pooling criteria and extrapolation from existing data sets can provide proxy information that may be used to achieve traditional biomonitoring goals.
